A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells. uri icon

authors

  • Daniel R. Goldstein MD
  • Chang, T
  • Sweeney, S D
  • Kirklin, J K
  • Thomas, J M
  • George, J F

publication date

  • January 1, 2000